Friday, September 28, 2018

FDA Announces Compounding Research Projects
NASEM will examine the use of compounded bioidentical hormone replacement therapy (BHRT) products, such as progesterone and testosterone, 
-

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)